China: China And Switzerland: The FTA And Medical Devices

Last Updated: 20 June 2014
Article by Christoph Huegli and Nathan Kaiser


This article outlines the implications of the new Free Trade Agreement (FTA) between China and Switzerland in relation to the trade in medical devices. There will be a special focus on the impact on tariffs, the applicable rules of origin, and the reduction of technical barriers to trade.

The FTA was signed on 6 July 2013, and is expected to enter into force in the second half of 2014.1 The agreement's general aim is to improve mutual market access for goods and services. The agreement is also to enhance legal security for the protection of intellectual property and bilateral economic exchange. It shall further contribute to sustainable development, and deepen bilateral cooperation between the parties. 2

For goods in particular, such as medical devices, the FTA widely reduces and eliminates tariffs. It includes a set of rules of origin, so as to determine whether or not a product falls under its protection. It specifies provisions for trade facilitation and a set of trade remedies in case of threat of serious damage to either party's domestic market. It also includes regulations on technical barriers to trade (TBT), plus sanitary and phytosanitary (SPS) measures.3

Tariff Reductions


The FTA specifies that the parties are to eliminate or reduce customs duties imposed on the importation of products originating from either party.4 This does not include equivalents to internal taxes, anti-dumping or countervailing duties or fees and charges of any kind imposed in connection with the importation commensurate with the cost of services rendered.5

Customs duties for most industrial products exported from Switzerland to China are to be gradually adjusted over time (depending on the product in 0-, 5-, 10-, 12- and 15-year periods), whereas industrial products exported from China to Switzerland are instantly freed of customs duties. The explanation for this difference is China's claim to have a specific need for adjustment given the sometimes substantially higher level of tariffs than Switzerland.6

The schedules for tariff reductions for particular products are set out in the FTA's Annex I and its Appendixes I (for China) and II (for Switzerland).

China Adjustment Specifics (Appendix I to Annex I)

The periodical reduction rates for tariffs on products entering into China are to be applied to the "most-favoured nation" rate applied on 1 January 2010, included in the charts of the Appendixes as the "base rate".7 The most-favored nation rate means the lowest customs duties rates granted to any other trade partner by China. Upon entry into force of the FTA, there will be an instant drop of these rates of customs duties for all goods to a new "preferential rate", with the exception of those goods that have no preference. The preferential rate is an exclusive rate granted under the FTA by China to Switzerland. There will be another drop of this preferential rate on 1 January of the following year and from then on annually on this date.8

Switzerland Adjustment Specifics (Appendix II to Annex I)

As mentioned above, in contrast to China, there is no gradual adjustment of customs duties on products entering into Switzerland. All customs duties will instantly, as categorized in Appendix II, either be classified under:

  1. Category A (Completely freed);
  2. Categories B1, B3 and C (Be partially dismantled); or
  3. Category D (Will have no preference at all); upon entering into the agreement.

In contrast to the customs duties and reductions imposed by China, those specified by Switzerland aren't defined as percentages but as absolute sums in CHF.9

Medical Devices

According to the World Health Organisation (WHO), the definition of a medical device is as follows: any instrument, apparatus, implement, machine, appliance, implant, in vitro reagent or calibrator, software, material or other similar or related article, intended by the manufacturer to be used, alone or in combination, for human beings for one or more of the specific purposes of; diagnosis, prevention, monitoring, treatment or alleviation of disease, diagnosis, monitoring, treatment, alleviation of or compensation for an injury, investigation, replacement, modification, or support of the anatomy or of a physiological process, supporting or sustaining life, control of conception, disinfection of medical devices, providing information for medical purposes by means of in vitro examination of specimens derived from the human body and which does not achieve its primary intended action in or on the human body by pharmacological, immunological or metabolic means, but which may be assisted in its function by such means.10

Appendixes I and II to Annex I list a number of categories of products that fit the WHO definition. 11

China (Appendix I to Annex I)

Appendix I for China includes 28 categories of products that can be qualified as medical devices. The description includes instruments and appliances used in medical, surgical, dental and veterinary sciences, including scintigraphic apparatus, other electro-medical apparatus and sight-testing instruments. Of the listed categories, 12 are immediately freed from customs duties (Category A), nine are gradually freed over five years (Category B) and seven will be freed after the completion of 10 years (Category C1). Most of these are subject to a base rate of four percent under the most-favoured nation rate of 1 January 2010, which will be eliminated for all of these products at the end of the respective transitional period. None are subject to only partial dismantling of the tariff rate.12

Switzerland (Appendix II to Annex I)

Appendix II for Switzerland lists 13 categories of products that can be qualified as medical devices. They all fall into Category A, which means customs duties are all eliminated upon entry into force of the FTA.13

Rules of Origin

As the FTA only grants preference to products originating in either Switzerland or China,14 it includes a set of rules of origin.15

Originating products must alternatively fulfill one of the following requirements:

  1. They must be wholly obtained in a party; or
  2. They must be produced in a party exclusively using originating materials of one or both parties; or
  3. Where non-originating materials are used in the production process, the non-originating materials must undergo a substantial transformation in a party.16

In the last case, a certain relation of the value of non-originating materials used and the value of the ex-works price of the product must be maintained. This relation is called "VNM%".17

Annex II lists product-specific rules for products to have preference under the FTA. These are applicable to products of either party. Annex II refers to the International Convention on the Harmonized Commodity Description and Coding System in which medical devices are classified under Chapter 90. The only product-specific rule in Annex II for this chapter is the VNM%.18 The specified VNM% for medical products is 55 percent. The value of non-originating materials used in the production process of medical devices can not exceed 55 percent of the value of the ex-works price, in order for it to have preference under the FTA.

Trade Facilitation

Chapter 4 of the FTA includes a set of rules on trade facilitation and customs procedures. It commits the parties to implement customs procedures in compliance with international standards and to make the laws and regulations relevant for the movement of goods available to the public. The parties also agree to base customs controls on objective risk analyses and to issue binding information on tariffs and country of origin to economic operators.19

Trade Remedies

Chapter 5 of the FTA lists a set of trade remedies that includes anti-dumping measures, subsidies and countervailing measures. For these the FTA refers to the relevant WTO provisions.20 In addition to the WTO provisions, the FTA sets forth that the parties have to consult each other with a view to finding an acceptable solution before making use of the measures provided in Chapter 5 of the agreement.21

The FTA, under certain conditions, also allows for the application of bilateral safeguard measures. Notably, if tariff concessions of the FTA lead to a new level of imports that could cause serious damage to a domestic industry, tariff concessions may be temporarily suspended.22

Reductions of Technical Barriers to Trade (TBT)

A big technical barrier to trade with China for medical devices is the costly and long process for products to be approved by the authorities in order for them to be sold.

New and Incorporated Regulations

Chapter 6 of the FTA addresses technical barriers to trade (TBT). Its objective is to facilitate bilateral trade and access to respective markets for goods falling under the scope of the chapter.23 Furthermore, the parties shall strengthen their technical cooperation in various areas, in view of increasing the mutual understanding of their respective systems.24

The FTA incorporates the existing WTO Agreement on Technical Barriers to Trade (WTO TBT Agreement), mutatis mutandis,25 and includes rules that go further than the TBT Agreement, e.g. it specifically names standards issued by the International Organization for Standardization (ISO), the International Electrotechnical Commission (IEC), the International Telecommunication Union (ITU) and the Codex Alimentarius Commission that are to be considered relevant for goods traded under the FTA.26

Along with the FTA there are several side agreements concerning TBT, such as the Agreement on Cooperation in the Area of TBT and SPS, and the Agreement on Cooperation in the Area of Certification and Accreditation.27


The WTO TBT Agreement expresses that the parties are to ensure that conformity assessment results of other members are recognized, provided there is confidence that the procedures are equivalent, even if different.28 In coherence the FTA stipulates that the parties are to promote the accreditation of conformity assessment bodies on the basis of relevant standards and guides of the ISO and IEC, and to encourage the mutual acceptance of conformity assessment results of such accredited bodies.29

The side agreements on certification and accreditation and TBT and SPS further mean the parties are to cooperate on compulsory and voluntary certification schemes and accreditation,30 to promote communication and cooperation between the respective competent authorities and certification and accreditation bodies of the two parties31 and for these bodies to carry out cooperation activities under the side agreements.32

In order for these cooperation schemes to reach their determined affect, the FTA also establishes a Sub-Committee on Technical Barriers to Trade under the Joint Committee that specifically monitors the implementations of the rules concerning TBT.33

According to the SECO, the extent of the practical implications of this new set of rules and its facilitations for certification and accreditation of products can't yet be determined. An improvement of the current situation, however, is anticipated.34


Concludingly the FTA will bring notable trade advantages for both parties. Tariffs will be widely eliminated or reduced on both sides, especially for medical devices. Tariffs on products being imported into Switzerland are instantly upon entry into force of the FTA eliminated, and tariffs on products being imported into China are also eliminated, albeit over a five- to 10-year transition period.

The rules of origin of the FTA specify where non-originating materials are used in the production process, these must undergo a substantial transformation. For medical devices, their value in relation to the ex works price of the product must be no more than 55 percent (VNM%).

As for the reduction of non-tariff barriers, the certification and accreditation process for medical products is expected to improve by the establishment of a set of rules to further the cooperation and communication between the parties. Such rules shall, amongst others, include the promotion of accreditation of conformity assessment bodies and the recognition of their results, the adoption of four international standards and the introduction of a sub committee on TBT.


1According to information provided by the Swiss State Secretariat for Economic Affairs (SECO) (22.8.2013)

2 Factsheet FTA CH-China, p. 1

3 Factsheet FTA CH-China, p. 1

4 FTA art. 2.3.2.

5 FTA art. 2.3.1.(a), (b), (c), the terms are consistent with the GATT (General Agreement on Tariffs and Trade) 1994 and the relevant rules therein (paragraph 2 Art. III, Art. VI and Art. VIII) apply to (a), (b), (c), respectively.

6 Factsheet FTA CH-China, p. 2

7 FTA art. 2.4.1.

8 Appendix I to Annex I of the FTA, A. explanatory notes

9 Appendix II to Annex I of the FTA, A. explanatory notes

11 They are coded with the ciphers 9018 and following, for the first four digits of the tariff line code number in both Appendixes I and II to Annex I.

12 Appendix I to Annex I of the FTA, A. explanatory notes and p. 522-524

13 Appendix I to Annex II of the FTA, A. explanatory notes and p. 384-385. In contrast to China, Appendix II for Switzerland doesn't include an overhead title. It does however follow the same coding starting with the digits 9018 and above

14 FTA art. 1.2

15 FTA art. 3.1

16 FTA art. 3.2 (a), (c)

17 FTA art. 3.2 (b) icw art. 3.4.3

18 Annex II of the FTA, p. 1 icw p. 16 and FTA art. 4.9

19 Factsheet FTA CH-China, p. 3

20 Factsheet FTA CH-China, p. 3

21 Factsheet FTA CH-China, p. 3

22 FTA art. 3.1

23 FTA art. 6.1.(a)

24 FTA art. 6.5

25 FTA art. 6.2

26 FTA art. 6.4 icw TBT Agreement art. 2.4

27 SPS meaning Sanitary and phytosanitary measures in the sense of FTA chapter 7

28 TBT Agreement art. 6.1

29 FTA art. 6.5.(d) and (e)

30 Agreement on Cooperation in the Area of Certification and Accreditation (CaA Side agreement) art. 1 and Annex III to Agreement on Cooperation in the Area of TBT and SPS (TBT SPS Side agreement) art. 1

31 CaA Side agreement art. 2 and Annex III to TBT SPS Side agreement art. 2

32 CaA Side agreement art. 3 and Annex III to TBT SPS Side agreement art. 3

33 FTA art. 6.7 and Agreement on Cooperation in the Area of Certification and Accreditation art. 5

34 According to Information provided by SECO (22.8.2013)

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.